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Abstract. Polyclonal isoenzyme-specific antisera were
developed against four calcium-independent protein ki-
nase C (PKC) isoenzymes (S, e, e', and ~) as well as
the calcium-dependent isoforms (a, 01, ßn, and -y).
These antisera showed high specificities, high titers,
and high binding affinities (3-370 nM) for the peptide
antigens to which they were raised . Each antiserum
detected a species of the predicted molecular weight
by Western blot that could be blocked with the im-
munizing peptide. PKC was sequentially purified from
rat brain, and the calcium-dependent forms were
finally resolved by hydroxyapatite chromatography.
Peak I reacted exclusively with antisera to PKCy,
peak II with PKCß, and -ßu, and peak III with PKCa.
These same fractions, however, were devoid of im-
munoreactivity for the calcium-independent isoen-
zymes. The PKC isoenzymes demonstrated a distinc-
P
ROTEIN kinase C (PKC)' plays a major role in trans-
membrane signal transduction (35). PKC is activated
by diacylglycerol, which is generated from membrane
phospholipids upon stimulation of cells with various agonists
(4). PKC also serves as the receptor for phorbol esters and
related tumor promoters (34), which activate the kinase by
substituting for endogenous diacylglycerol (8). Because of
the pleiotropic actions of diacylglycerol and phorbol esters,
PKC has been implicated in the regulation ofa variety of cel-
lular processes, including proliferation, differentiation, and
release of hormones and neurotransmitters (35, 36).
Molecular cloning studies have revealed that PKC consists
of a large family of at least eight different isoenzymes (36,
37) that can be divided into two major groups. Initially, four
isoforms of PKC were described. This group consists of
PKCca, -01, -ß,1, and -y, with PKCß, and -ß arising via al-
ternate splicing of the same gene transcript and resulting in
distinct carboxy-terminal regions. All four of these isoen-
1. Abbreviations used in this paper: PKC, protein kinase C.
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tive tissue distribution when evaluated by Western blot
and immunocytochemistry. PCKS was present in
brain, heart, spleen, lung, liver, ovary, pancreas, and
adrenal tissues. PKCe was present in brain, kidney,
and pancreas, whereas PKCe' was present predomi-
nantly in brain. PKCS was present in most tissues,
particularly the lung, brain, and liver. Both PKCS and
PKCr showed some heterogeneity of size among the
different tissues. PKCa was present in all organs and
tissues examined. PKCß, and -ßn were present in
greatest amount in brain and spleen. Although the
brain contained the most PKCT immunoreactivity,
some immunostaining was also seen in adrenal tissue.
These studies provide the first evidence of selective
organ and tissue distributions of the calcium-
independent PKC isoenzymes.
zymes show very high sequence homology and similar struc-
turalorganization with an amino-terminal regulatory region
and a carboxy-terminal catalytic domain (22, 36). The reg-
ulatory domain is characterized by two highly conserved
constant regions C, and C2, with C, containing two "zinc
finger" cysteine-rich regions. The activity of these four iso-
forms is characterized by strong dependencies on calcium,
phospholipid, and diacylglycerol (7, 36). It is thought that
the C2 region imparts calcium dependence (37), whereas
the C, region contains the phospholipid and diacylglycerol/
phorbol ester binding sites (41). Subsequently, a second
group of PKC isoenzymes was identified comprising the
PKCS, -e, -e', and -~ isoforms, with PKCe' arising as a splic-
ing variant of PKCe (40). This novel group of PKC isoen-
zymes exhibits calcium-independent activity that presumably
reflects the absence of the calcium-binding C2 domain (40).
Although the isoforms of PKC exhibit small differences in
their dependencies on lipid cofactors and overlapping sub-
strate specificities (7, 19, 30, 37), a major distinguishing
feature of PKC isoforms as a group is their distinct tissue
and cellular localization. However, the reported studies arelimited in scope and have not been extended to calcium-
independent isoenzymes. PKCce has been shown to display
a ubiquitous tissue distribution in one study (27) and a limited
peripheral distribution in another (56) . The ß isoenzymes
show a more restricted distribution (27, 56), although little
information is available on the relative distribution ofthe ßi
and On isoenzymes. Northern blot analyses (25, 39) and
limited immunologic studies (18, 27, 54, 56) indicate that
PKCy may be localized exclusively in the brain. By compari-
son, analysis of the tissue and cellular distribution of the
more recent members of the PKC family is restricted to a
limited Northern blot study with a rather conspicuous ab-
senceof immunologic determination ofthe PKCS, -E, -E', and
-~ isoenzymes in different tissues (40).
Because of the lack of information on the tissue distribu-
tion of the isoenzymes and because the specificities of most
of the available antisera to the conventional isoenzymes of
PKC are unknown, this study was undertaken. We describe
the development of antisera to eight PKC isoforms: PKCa,
-ßt, -ß,t, -y, -S, -E, -E', and -~ We demonstrate specificity of
the antisera by ELISA, fast protein liquid chromatography,
Western blot, and immunocytochemistry. Finally, we deter-
mine the tissue and cellular distribution of the novel PKC




Glutaraldehyde, 1-ethyl-3-(3-dimethylaminopropyl) carbodiindde hydro-
chloride, bovine thyroglobulin, Freund's complete or incomplete adjuvant,
O-phenylenediamine hydrochloride, and histone III proteins were pur-
chased from Sigma Chemical Co. (St. Louis, MO). Phosphatidylserine was
obtained from Avanti Polar Lipids, Inc. (Birmingham, AL). The sn-1,2-
dioleoylglycerol was prepared as described (32). PKC peptides were synthe-
sized by theProtein Chemistry Laboratory ofthe University ofNorth Caro-
lina at Chapel Hill and purified by HPLC on a Cis reverse-phase column
using a 0.1% trifluoroacetic acid buffer with acetonitrile gradient elution.
Immuno-Plate II 96-well plates for ELISA were bought from Nunc, Inc.,
(Naperville, IL). Peroxidase-labeled goat anti-rabbit IgG was obtained
from Kirkegaard and Perry Labs, Inc., (Gaithersburg, MD). Reagents for
SDS-PAGE and nitrocellulose paper were from Bio-Rad Laboratories,
(Richmond, CA). Additional reagents consisted of sheep anti-rabbit IgG,
rabbit peroxidase antiperoxidase, and normal sheep serum (Arnel Inc.,
Parlin, NJ), DAB and 4-chloro-I-naphthol (Aldrich Chemical Co., Milwau-
kee, WI), Panatomix X film (Eastman Kodak Co., Rochester, NY), [32P]-
ATP (New England Nuclear, Boston, MA), and GF/c filters (Whatman
Inc., Hillsboro, OR).
Antiserum Production
Unique amino acid sequences from each ofeight different PKC subspecies
were selected and synthesized (Table I). NHZ terminally derived PKCe and
-É peptides were conjugated with carbodiimide to thyroglobulin as de-
scribed (13). After reaction for 18 h at 23°C, the mixture was dialyzed and
stored at -20°C in volumes appropriate for the initial injection and subse-
quent booster injections.
All of the COON terminally derived PKC peptides were mixed with
thyroglobulin as described (10). Glutaraldehyde was added dropwise over
a 30-min period to a final concentration of0.1% . This mixture was allowed
to stir for an additional 45 min at 23*C before glycine was added to bring
the solution to 0.2 M. This mixture was dialyzed and stored as outlined
above.
Amisera to each ofthenine PKC-conjugatedpeptides wereraised in male
and female New Zealand rabbits (2.3-3.2 kg). Initially, each rabbit was
given 0.8 mg of conjugate in multiple intradermal and subcutaneous injec-
tions (10). Later, each rabbit was boosted with 0.2 mg of conjugate in 0.5
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TableI. AminoAcid Sequences ofPKC Peptides Used
to Generate Antisera
The amino acid sequences for PKCct, -ß,, -ß, --y, -6, -E, and -f are
located at the extreme COOH terminus of these enzymes.
* The peptides were purified by HPLC to a single peak, but no amino acid
analysis was run. In these calculations, it is assumed that the peptides were
pure.
t The sequences for PKCe and PKCe' are found at the extreme NHZ-terminal
region of these enzymes.
Kd: dissoocaation constant.
ml of Freund's incomplete adjuvant. Rabbits were boosted at 6-wk intervals
and bled 10-14 d after each boost.
ELISA Assays
ELISA assays were used to examine the antiserum titer ateach bleedingand
to determine the affinity and immunological specificity ofthe antisera. Ap-
proximately 6-30 pmol of peptide antigen (Table I) was solubilized with a
3.5 mM sodium bicarbonate/1.5-mM sodium carbonate solution (pH 9.6),
and added to wells on Immuno-Plates. All incubations were performed at
23°C. After 2 h, a PBS/0.5% BSA-blocking solution was added, followed
by the primary antiserum (1:2,b00-1:256,000). The wells were washed in
a PBS/0.1 % gelatin solution, andthen peroxidase-labeled sheep anti-rabbit
IgG antiserum was added, and color was developed with a 2.5-mM citrate/
5-mM phosphate solution containing O-phenylenediamine hydrochloride
and hydrogen peroxide. The reaction was stopped with 8 N sulfuric acid
and the plates were read at 492 nm with a multiscan MC spectrophotometer
(Titertek, Helsinki, Finland).
An antigen-antiserum-binding curve was established by adding increas-
ing concentrations of the antigenic peptide (until absorbance plateaued in
the ELISA) to a single dilution of antiserum. After subtraction of back-
ground absorbance from each reading, this binding curve was normalized
by setting the maximal absorbance for the antigenic peptide equal to 100%
binding. Immunological specificity was determined by adding different con-
centrations (10-5,000 pmol) of the other eight peptides to the assay and
comparingtheir absorbances to the antisera. Cross-reactivity oftheantisera
for each oftheseeight comparison PKC peptides was assessed by normaliz-
ing the data as described and comparing them with the normalized scores
for the antigenic peptide. Since the midpoint on the binding curve approxi-
mates the dissociation constant of the antiserum for the peptide antigen,
these binding affinities were also estimated.
Preparation of7Fssue Extractsfor Western Blotting
Rats (200-250g) were decapitated and thedesired organs were immediately
removed, weighed, and transferred into ice-cold homogenizing buffer (20
mM Tris-HCI, pH 7.5, 0.25 M sucrose, 10 mM EGTA, 1 mM EDTA, 10
mM ß-mercaptoethanol, 1 mM PMSF, 0.02% leupeptin, and 0.1% Triton
X-100). The homogenate was incubated for 1 h at 4°C and centrifuged at
100,000 g for 30 min at 4°C. An aliquot ofthe supernatant was taken for
protein determination (5), while the remainder was immediately mixed (1:1)
with 2x SDS sample buffer (28) and heated in a boiling water bath for 5
min. The boiled samples were either used immediately or frozen at -20°C
for SDS-PAGE.
PurificationofPKCFromRatBrain
PKC was purified from rat brain cytosol according to the modified fast pro-
tein liquid chromatography procedure of Kitano et al. (24). Briefly, rat
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PKC isoenzyme Amino acid sequence Reference Kd values*
nM
Rat PKCa 657SYVNPQFVHPILQSAV672 22 99.0
Rat PKC/3, 1'SYTNPEFVINV6" 22 46.0
Rat PKC0 ISFVNSEFLKPEVKS673 22 10.5
Rat PKCT 6'DARSPTSPVPVPVM697 22 20.0
Rat PKCS 66zSFVNPKYEQFLE673 40 3 .6
Rat PKCe 726KGFSYFGEDLMP"' 40 28 .0
Rat PKCe$ IMVVFNGLLKIKI12 40 370.0
Rat PKCe'$ 'MPHKFGIHNYK" 40 180.0
Rat PKCS 5,9EYINPLLLSAEESV592 40 13.0brains were homogenized in the homogenizing buffer as described above
except Triton X-100 was omitted. The homogenate was centrifuged at
100,000 g for 1 h at 4°C. All the subsequent procedures were performed
at 4°C. The supernatant was purified by sequential chromatography on
DEAE-sephacryl, threonine-sepharose, and phenyl-sepharose columns.
Fractions containing peak activity after the last column were pooled and
subjectedto hydroxyapatite column chromatography according to Huang et
al. (19). The column was equilibrated with buffer B (20 mM potassium
phosphate buffer, pH 7.4, 10 mM ß-mercaptoethanol, 10% glycerol) . The
enzyme was eluted by a linear gradient of20 to 300 mM potassium phos-
phate in 80 ml buffer B. Every other fraction was assayed for calcium/phos-
phatidylserine/sn-1,2-diacylglycerol-dependent activity as described (12).
Western BlotAnalysis
Tissueextractspreviously boiled in samplebuffer or fast protein liquid chro-
matography-purified peak fractions were subjected to 12 % SDS-PAGE ac-
cording to the method of Laemmli (28). The separated proteins were elec-
trophoretically transferred to nitrocellulose at 4°C overnight by the method
ofTowbinet al. (53). Nonspecific binding sites on nitrocellulose paper were
blocked by incubation with 5% nonfat dry milk in 1x PBS for 1 h at room
temperature. The nitrocellulose sheets werethen incubated with the respec-
tive PKC antisera (1:750-1:4,000 dilution) for 2 h at room temperature. Af-
ter three washes with 5% nonfat milk in lx PBS at 15-min intervals and
a wash with PBS, secondary antiserum (goat anti-rabbit labeled with HRP
at 1:1,500 dilution) was added and incubated for 2 h at room temperature.
The paper was subjected to three 5-min washes with 5 % nonfat dry milk,
followed by one 5-min wash with PBS, and then color was developed using
hydrogen peroxide and 4-chloro-l-naphthol according to the manufacturer's
instruction.
To demonstrate specificity of immunoblotting, the cerebellar extracts
were run in the presence or absence of the appropriate antigenic peptide.
For this specificity test, 2 jig/nil of each of the peptide antigens (Table I)
was added to the respective primary PKC antisera just before addition to
the blot. Subsequent washes, addition of secondary antisera, and color de-
velopment were performed as described above.
Immunocytochemistry
Male and female Sprague-Dawley rats (250-300 g) were anesthetized with
tribromoethanol (1.0ml/100g body wt) andperfused through the ascending
aorta with 30 ml of 1% phosphate-bufferedparaformaldehyde (pH 7.4), fol-
lowed by 150 ml of 4% paraformaldehyde in the same phosphate buffer. 30
min after perfusion, the brain, cerebellum, ovary, testes, liver, heart, lungs,
spleen, pituitary gland, pancreas, and adrenal glands were removed and im-
mersed in the same fixative. The next day, brains or cerebellum were cut
into smaller pieces and sliced at 30 lam with a vibratome (Technical Prod-
ucts International, Inc., St. Louis, MO). The peripheral tissues were de-
hydrated in a series ofgradedalcohol steps and embedded in paraffin. These
paraffin-embedded tissues were serially cut at 5 to 71ím. After deparaffini-
zation, sections were treated with trypsin (11), exposed to 2% normal sheep
serum, andthen incubated with anti-PKC sera (1:1,000-1:4,000 dilution) for
48 h at 4°C in a humid chamber. Sections were stainedbythe double peroxi-
dase antiperoxidase technique (44), washed with PBS, and exposed to
OsO4 vapors to enhance the intensity of staining. Finally, the sections were
counterstained with toluidine blue.
Brain and cerebellarvibratome sections were collected in glassvials and
treated as described (33). The sections were exposed to 2% normal sheep
serum and stained while floating in antisera. The rabbit anti-PKC sera
(1:1,000-1:4,000 dilution) were added to the sections and incubated for 24 h
at4°C. All subsequent incubations were performedat room temperature for
30 min. After a rinse in PBS, the sections were incubated with sheep anti-
rabbit IgG (1:500 dilution), washed again with PBS, and incubatedwith per-
oxidase antiperoxidase serum (1:1,000 dilution), and then color was devel-
oped with DAB (40 mg/ml) and 0.002% hydrogen peroxide.
Results
ELISA Characterization ofAntisera
Antisera to PKCa, -ß,, Oft, -y, -S, -e, and -~ were devel-
oped . Three different antisera were developed for PKCe (Ta-
ble I); two were made to the NHZ-terminal region of this
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species to distinguish PKCe from PKCe' (40), whereas a
third was targeted to the extreme COOH terminus of PKCe
(PKCe and PKCe' have the same COOH-terminal sequence) .
Titers for all antisera were high on the firstbleeding, and they
continued to increase over additional bleedings. In initial
characterization studies, we used the ELISA to establish
binding curves and then examined cross-reactivity of each
antiserum to each of the different PKC-derived peptides (Ta-
ble I) . Distinct antisera were developed for each of the iso-
forms. All antisera showed high titers (1:2,000-1:256,000 di-
lution) and demonstrated very high affinities for their
respective antigenic peptides. The estimated dissociation
constants for all of the COOH terminally directed antisera
ranged from 3 to 99 nM (Table I) . Antisera to the NHZ ter-
minally derived PKCe and PKCe' had somewhat higher dis-
sociation constants for their respective peptides at 370 and
180 nM (Table I), probably due to the hydrophobic nature
of these peptides. All binding curves displayed a sigmoidal
shape, suggesting that each polyclonal antiserum was rela-
tively homogeneous with respect to the recognition site for
the antigenic peptide (data not shown). Cross-reactivity for
the different peptide antigens was always <7 % at doses up to
50 AM (data not shown). Hence, all antisera appeared to be
highly specific for the peptide to which they were raised.
These results demonstrate the high titers, affinities, and
specificities of these antisera for their respective antigenic
peptides.
Characterization ofAntisera againstPKC Isoenzymes
Western blot studies have shown that PKCa, -ß, and -y are
present in rat cerebellum, and gene expression experiments
have demonstrated that the mRNAs for PKCS, -e, and -~ are
present in rat brain (16, 40). Therefore, in our studies we
used a cerebellar extract to further characterize our
isoenzyme-specific antisera. Western blot analysis of the
cerebellar extract with the COOH-terminally directed PKCU,
-ß,, -ßu, -y, -e, -S, and -~ antisera showed immunoreactivi-
ties at 72-90 kD (Fig. 1) . PKCa, -ß,, -ßn, and -y were all
detected at -80 kD (Fig. 1) . A minor immunoreactive band
was recognized at -31 kD by the PKCO, antiserum. This
low molecular mass band and all other bands at N80-kD
were displaced by competition with 2 Ag/ml of the respective
antigenic peptide (Fig. 1) . These results are in agreement
with previous Western blot studies suggesting that PKCa,
-ßt, -ßn, and -y are -80 kD in size (17, 27, 56). In addition,
this size is consistent with the cDNA cloning and sequencing
data (9, 25).
The COOH terminally directed PKCS, -e, and -~ antisera
detected immunoreactive bands at -80, 90, and 72 kD,
respectively (Fig. 1) . The PKCS antiserum recognizeda sin-
gle immunoreactive species, and this 80-kD band was suc-
cessfully competed with peptide. Frequently, the PKCe an-
tiserum immunostained materials as a doublet at -90-94
kD. A third faint band can also be seen at -50 kD in this
blot. The higher molecular mass bands were displaced by the
addition of antigenic peptide, whereas inununoreactivity re-
mained at the lower molecular mass. The PKCS antiserum
recognized materials at -50, 72, and 80 kD, with the pre-
dominant band migrating at 72 kD. The 50- and 72-kD bands
disappeared with the addition of the antigenic peptide. Two
points should be made. First, the sizes of the materials de-
tected by our PKCS and -e antisera are consistent with the
123Figure 1 . Specificityofthe different C-terminally derivedPKC antisera . Fresh cerebellarextract (28 ug protein) was subjected to SDS-PAGE
and transferred to nitrocellulosepaperasdescribed in Materials and Methods . Immunoblotting was performed using each antiserum (1.750-
1:4,000 dilution) with (+) or without (-) the respective peptide (2 pg/ml) added just before addition to the blot . Std ., standard .
sizes (e.g ., 80-90 kD) observed both with Western blots (23,
42, 49) and predicted from the cDNA cloning data (39, 40) .
The PKCt isoform identified in cerebellum was found to be
somewhat larger than that reported in transfected COS cells
(42) . This discrepancy may be attributed to differences in
posttranslational processing, becausewe observed the PKCr
immunoreactive species to be ofdiffering sizes in various tis-
sues (see below) . Second, protein bands of 70-90 kD were
all successfully competed with the corresponding antigenic
The Journal of Cell Biology, Volume 117, 1992
peptide . Hence, these antisera appeared to recognize the ap-
propriate PKC species to which they were raised .
In addition to the PKC antisera, which were targeted to
the COOH terminal regions of these seven PKC species, we
also developed antisera to the N112-terminal regions of
PKCe and PKCe . The PKCe antiserum bound material at
-90 kD, whereas the PKCe' antiserum recognized a major
band at -55 kD and a minor band at -90 kD (data not
shown) . This high molecular mass band detected at 90 kD
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Figure 2 . Specificity ofPKCa, -ß,, -ßu,
and -y antisera against hydroxyapatite-
resolved PKC isoenzymes. Immunoblot
analysis of type I, II, and III isoen-
zymes : pooled fractions containing
equal kinase activity were subjected to
SDS-PAGE and then transferred to nitro-
cellulose paper and immunoblotted with
each of the antisera . The arrow indicates
the position of PKC .by the PKCe' antiserum may represent PKCe, because this
PKC isoform contains an internal amino acid sequence cor-
responding to e' (e' is a truncated splice variant of e and does
not offer unique sequence [40]) . In addition, these immuno-
reactive bands were successfully competed by the respective
peptide antigen (data not shown) . However, these antisera
were difficult to use for Western blotting, and, as a result,
the COOH terminally directed PKCe antiserum was used in
all subsequent immunoblots for detection of PKCe.
Specificity ofAntisera Using PurifiedPKC Isoenzymes
PKCa, -ß, and -y isoenzymes can be resolved chro-
matographically on hydroxyapatite with increasing phos-
phate concentrations (19) . In our studies, we used sequential
chromatography followed by a hydroxyapatite separation at
the final step . This procedure permitted us to separate, as a
group, the calcium-independent forms ofPKC from the de-
pendent forms, because the calcium-independent isoen-
zymes elute at a higher salt on DEAE . Hence, during
hydroxyapatite separation, the remaining calcium-dependent
forms were resolved into three different peaks (data not
shown) .
Western blot analysis of these peaks is shown in Fig. 2 .
It is evident from these results that type I PKC reacted with
Figure 3 Tissue distribution of different PKC isoenzymes in the rat. Total tissue extract (28 pg protein) was separated by SDS-PAGE and
immunobloned as described in Materials and Methods . The PKCci and -f antisera were used at 1:4,000 and 1:750 dilutions, respectively .
All other antisera were used at a 1:1,000 dilution .
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125the PKC-y antiserum, and peak II reacted with both the
PKCß, and -ß antisera, with PKCß showing higher reac-
tivity than PKCß,. Peak III reacted with the PKCca antise-
rum and, to a much lesser extent, with the PKCß, antise-
rum. A similar finding has been reported by others (19) .
These results demonstrate that the PKCca, -ß,, -ßt,, and --y
antisera are selective and biochemically specific for the
isoenzymes against which they were raised .
Because ofour separation scheme, the separated peaks on
hydroxyapatite did not show any cross-reactivity with the
PKCS, -e, and -~ antisera (data not shown), again emphasizing
the immunospecificity of each of the antisera. These results
also demonstrate that the purified and separated PKCa, -ß,
and -7 isoenzymes are not contaminated with PKCS, -e, or
when sequential chromatography precedes the hydroxy-
apatite separation. Hence, this separation scheme removes
PKCe as a possible coeluting species in the PKCß peak when
only hydroxyapatite chromatography is used (see [26, 49]) .
71ssue Distribution ofPKC Isoenzymes
We used isoenzyme-specific antisera for Western blotting to
detect the presence of the PKC«, -ß,, -ß, -y, -S, -e, and -~
isoforms in extracts from rat tissues prepared from brain,
lung, heart, spleen, liver, testes, ovary, and kidney. These
results are depicted in Fig. 3 and Table II. Because the an-
tisera have differing affinities for their peptide antigens and,
presumably, for the corresponding PKC isoform, compari-
sons in relative immunostaining among tissues can be made
for a given antiserum but not among antisera. During the
preparation of samples for immunoblotting, we found that
rapid processingof the organs was essential to minimize the
appearance of low molecular mass bands on the gels (indica-
tive of PKC degradation because they could be competed
with antigenic peptides) . In Fig. 3, the immunoreactive
bands from the different tissues were the same size as those
found for the cerebellum (see Fig. 1), with few exceptions
as noted below.
When the blot was stained with the PKCa antiserum, an
80-kD band was visualized in all tissues examined (Fig. 3).
The spleen was particularly enriched with this isoform, and
dense bands were also obtained from lung and brain extracts
(Table II). Lighter bands were found in the ovaries, testes,
kidney, heart, and liver. The ubiquity of PKCa has been
reported by other investigators (1, 27, 29, 46, 55, 56). This
study corroborates these findings.
Table H. Relative Band Density ofPKC Isoenzyms in Various Tissues ofthe Rat as Detected by Western Blot Analysis
* Equal amounts of protein were loaded from each organ as described in Materials and Methods. The numbers indicate the relative density of immunostaining
with 5 being highest and 1 the least detectable staining.
t Strong specific staining of a 39-kD band was detected in testes.
ND, no staining detected.
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When blots were stained with the PKCß, antiserum, the
darkest staining occurred with the brain extract; somewhat
lighter staining was present in the spleen, and very faint im-
munoreactivity was visualized in the testes, lung, heart, and
ovary (Fig. 3; Table II). Dark immunostaining with PKCß,
antiserum, which was observed at 39 kD in testis extract,
disappeared with addition of antigenic peptide (data not
shown). The identity of this band is unknown; however, it
could represent a proteolytic fragment of PKCß,. Immuno-
blotting for PKCß revealed a dense band in brain extract
and spleen and very light staining in other tissues (Table II).
No staining was detected in liver with either PKC0, or -01,
antisera. Although PKCß, and -ß have been shown by
Western blotting to be present in rabbit and rat brain (1, 51),
they have not been localized specifically to these other tis-
sues. It should be noted, however, that other investigators
have detected PKCß (with no distinction between PKCß,
and -ß) in spleen, testes, and kidney (27) .
The PKC-y immunoblots revealed this isoform to be pres-
ent exclusively in brain (Fig. 3; Table II). Faint bands at -65
and 35 kD could not be competed with peptide in brain (data
not shown) . Our findings are consistent with previous studies
using Northern or Western blot analyses (6, 9, 25, 46).
PKCS was present as an 80-84-kD doublet in brain, lung,
spleen, ovary, and kidney (Fig. 3). In heart, liver, and testes,
it appeared as a single 80-kD band . A minor band at -50
kD was detected in spleen . All bands could be competed
with the antigenic peptide (data not shown) . Hence, PKCS
may have multiple molecular forms in different tissues.
PKCS was particularly prominent in brain (Fig. 3; Table II) .
Spleen and lung contained significant levels of PKCS, with
somewhat lower levels in ovary and heart, whereas testes,
kidney, and liver were found to express the least amount of
the PKCS isoenzyme. Although Western blot analyses have
not been previously applied to these tissues, Northern blots
have revealed PKCS to be expressed in brain, lung, spleen,
and kidney (40).
The PKCe antiserum bound material at -90-94 kD as a
doublet in brain and as an 80-kD species in kidney (Fig. 3) .
A very faintband at 50 kD was visualized in spleen and testes
that could not be competed with antigenic peptide (data not
shown) . Hence, this low molecular mass material must rep-
resent nonspecific binding. The immunostaining in the brain
was darker than in kidney, and little staining was detected in






Isoenzymes Brain Lung Heart Spleen Liver Testes Ovary Kidney
« 3 4 1 5 1 2 2 2
ß, 5 1 1 3 ND 1$ 1 ND
ßn 5 1 1 4 ND 1 1 1
-y 5 ND ND ND ND ND ND ND
S 5 4 3 5 2 1 3 1
e 5 ND ND ND ND ND ND 3
3 5 1 2 4 2 2 3Figure 4 . Immunocytochemical staining of the rat ovary, pancreas, testes, and hippocampus with polyclonal antisera to PKCa, PKCO,,
PKCO, and PKCy, respectively. In the ovary (A), the granulosa cells of the ovarian follicle are darkly stained. The open star represents
the antrum folliculi; the solid star indicates the ovum with the cumulus oophorus . In the pancreas (B), only peripherally located cells of
the islets of Langerhans (asterisk) are immunostained (arrowheads) . The exocrine glands are not stained . In the testes (C), the nuclei
ofthe Sertoli cells are immunostained . In the hippocampus (D), theCAl-CA3 regions are darkly stained . Theimmunostaining is located
in nerve terminals throughout these regions . The pyramidal cells (Py) seem to be surrounded by immunoreactive nerve terminals . The
paraffin sections (A-C) were counterstained with toluidine blue . The vibratome section is not stained . CC, corpus callosum ; HiF, hip-
pocampal fissure. Bars, 100 um .
from brain are in agreement with otherWestern and North-
ernblot data (1, 39, 40), theoccurrence ofPKCe in other or-
gans has not been studied previously. In addition, sincemul-
tiple transcripts for PKCe can exist both within the same
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tissue and among tissues (40, 50), PKCe isoenzymes of
differing sizes may exist in these tissues.
PKC~ migrated as a 72-80-kD band in different tissues
(Fig . 3) . PKC~wasmaximallyexpressed in lung and at lower
127Figure S . Immunostaining ofrat thalamus, heart, cerebellum, and anterior pituitary gland with antisera to PKCS,PKCe, PKCe', andPKC~,
respectively. The PKCS antiserum stains all neuronal cells in the thalamus, especially in the nucleus posterolateralis (A) . The terminal
portion of these neurons in the cortex is also immunostained (data not shown) . In the heart (B), longitudinally and cross-sectionedmuscle
fibers are immunostained.ThePKCe'antiserum stains cells in the molecularlayer (m), the granular layer (g), and fibers andnerve terminals
around Purkinje cells (P) in the cerebellum (C) . Within the pituitary gland, the medium and large round cells are immunostained (D) .
The paraffin sections are counterstained with toluidine blue (B andD) ; the vibratome sections are not counterstained (A and C) . w, white
matter of the cerebellum . Bars, 100 ttm .
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128levels in liver, brain, kidney, testes, spleen, and ovary (Table
II) . Extremely faint immunostaining was detected in heart .
The only published reports of PKC have localized it by
Western blots to brain and by Northern blots to brain, lung,
and kidney (40, 42) . Additional tissues were not examined
in those studies . Our results demonstrate the selective tissue
distribution not only of the PKCci, -ß,, -ßn, and -y isoen-
zymes, but also of the newly described PKC6, -E, and -~ iso-
forms .
Immunocytochemistry
To characterize the tissue and cellular distribution of these
PKC isoenzymes, immunocytochemical analyses were per-
formed with eight of the isoenzyme-specific antisera . For the
purposes of this analysis, all COOH terminally derived an-
tisera, except that for PKCE, were used . In the latter case,
the NH2 terminally derived antisera for PKCe and -E' were
used because they provided the better comparison forimmu-
nostaining . These cytochemical studies were performed on
sections from cerebellum, thalamus, pituitary gland, pan-
creas, pineal gland, liver, spleen, ovary, testes, adrenal
glands, lung, and heart . Immunoreactivity was determined
in the absence or presence of excess immunizing peptide .
Figs . 4-6 show representative tissues for each of the isoen-
zymes . We also examined immunostaining in cerebella sec-
tions (Fig . 7), a tissue in which some of this information is
partially known .
Antisera raised against PKCci stained granulosa cells of
the ovarian follicles (Fig . 4 A), Purkinje cells in the cerebel-
lum (Fig. 7 A), cells located peripherally to the islets of
Langerhans in the pancreas, and muscle cells of the heart .
Staining in the lung and spleen was related to stromal and
epithelioid cells, respectively. Staining was also observed in
adrenal and pineal glands, and faint immunoreactivity was
detected in testes and pituitary gland . This antiserum did not
stain structures in the liver at the dilution used. Although
many of these findings are novel, other investigators have
reported the presence of PKCce immunoreactivity in the pan-
creas (21, 43) and either the presence or absence ofmRNA
expression in spleen and liver (6, 21, 43) . The immunostain-
ing of Purkinje cells in the cerebellum is also controversial
(14, 18, 52) .
The PKC#, antisera stained peripheral cells within the is-
lets of Langerhans ofthe pancreas most intensely (Fig. 4 B) .
It also stained cells in the stratum granulosum of the cerebel-
lum (Fig . 7 B), granulosa cells of the ovarian follicles, the
spleen, heart, adrenal glands, and lung . Very light staining
was observed in the testes, where the Sertoli cells and differ-
ent cell types ofthe spermatogenetic line showed lightimmu-
nostaining . No immunostaining was seen in the liver or pitu-
itary gland. Our Western blot and cytochemical findings for
liver and spleen are in concert with in situ hybridization data
(6) . In addition, other investigators have observed the gran-
ular layer of the cerebellum to show ß, immunoreactivity
(2, 15, 52) and to express this RNA species (6) .
PKCf, t antisera stained Sertoli cells and cells of the sper-
matogenetic line in the testes (Fig. 4 C), cells in the stratum
granulosum ofthe cerebellum (Fig . 7 C), peripheral cells of
the islets of Langerhans, granulosa cells of the ovarian folli-
cles, and cells in the lung, spleen, adrenal glands, and heart.
Figure 6 . Immunostaining of rat adrenal gland with antiseruin against PKC (A) . Both the cortex and the medulla contain PKCeimmuno-
positive cells . The border between the medulla and cortex is indicated by arrowheads . The medulla is shown by an asterisk. Following
preabsorption of the antiserum with 1012g PKCf peptide per milliliter working dilution of the antiserum, the immunostaining was com-
pletely blocked (B) . Paraffin sections were counterstained with toluidine blue . Bars, 100 jam .
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129Figure 7 . Immunostaining for different isozymes of PKC in the rat cerebellum. PKCa (A) is present in Purkinje cells (P) . The dendrites
of these cells canbe followed as far as the top ofthe molecular layer (m) . The granular layer (g) andthe white matter (w) are not stained .
To avoid crowding, the abbreviations for layers of the cerebellum are indicated only in (A) ; however, the layer of Purkinje cells (P) is indi-
cated in each figure for orientation. PKCO, (B) and PKCßn (C) are present only in cells of the granular layer. PKC7 is present in Purkinje
cells andBergmann glial cells in the molecular layer (D) . Not only the perikarya but also the dendrites of Purkinje cells in the molecular
layer and their axons inthe granularlayerare immunopositive. Theantiserum forPKCS stained Purkinje cells (E)and presently unidentified
cells below the unstained Purkinje cells (F) . The dorsally located folia contain mainly unstained Purkinje cells. Their axonal origin is
surrounded by immunopositive cells . In the basal folia, the Purkinje cells are immunostained . PKCe is present in Purkinje cells (G),
whereas PKCe' is present in cells in the molecular and granular layers and in the nerve fibers surrounding the unstained Purkinje cells
(H) . Antiserum against PKC~ stained only Purkinje cells in the cerebellum (I) . Bars, 100 gym .
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130It did not stain cells in the liver or pituitary gland. Once
again, our findings confirm RNA expression data in spleen
(6) and immunologic findings in cerebellum (2, 52). In-
terestingly, PKCß immunostaining in cerebellum has been
reported by the same group to be localized either to the mo-
lecular or granular layer and Bergmann fibers (2, 47). An-
other group has also observed PKCß immunoreactivity in
the molecular and granular layers of the cerebellum (52).
Antisera against PKCy stained the CAI-CA3 region of the
hippocampus (Fig. 4 D), cell bodies, and dendrites of Pur-
kinje cellsvery intensely,and less intensely stained Bergmann
glial cells and fibers in the white matter of the cerebellum
(Fig. 7 D) . No staining was observed in any other tissues ex-
amined except for adrenal cortex and pancreas, which
stained very lightly. Our cytochemical findings in hip-
pocampus and cerebellumare in agreement with the findings
of others (2, 16, 18).
Antisera against PKCS stained the thalamus, especially the
nucleus posterolateralis (Fig. 5 A), Purkinje cellsof the cere-
bellum (Fig. 7, E and F), granulosa cellsof the ovarian folli-
cles, and peripherally located cells in the islets of Langer-
hans. Staining was also observed in the lung, spleen, adrenal
glands, and heart. No staining was seen in liver, testes, or
pituitary gland.
The PKCe antiserum stained cells in the heart (Fig. 5 B),
Purkinje cells in the cerebellum (Fig. 7 G), cellsin the islets
of Langerhans, spleen, ovaries, adrenal glands, and lung. It
also showed modest staining in Sertoli cells of the testes. No
staining was seen in liver or pituitary gland.
Antisera against PKCe' stained only nerve terminals
around Purkinje cellsand Golgicells in the stratum granulo-
sum of the cerebellum (Fig. 5 C and Fig. 7 H) . Some stain-
ing was detected in adrenal glands, pancreas, and ovary.
Faint immunoreactivity was seen in heart, spleen, and testes,
whereas liver, lung, and pituitary gland showed no staining.
PKCS immunoreactivity was present in middle-sized and
round cells of the pituitary gland (Fig. 5 D). The PKCS an-
tisera stained Purkinje cellsand processes of Bergmann glial
cells in the cerebellum (Fig. 7 I) . This antiserum stained
cells in the zonae glomerulosa, fasciculata and reticularis of
the adrenal cortex, and cellsin the medulla (Fig. 6) . Interest-
ingly, not all the cells in these layers were stained. This an-
tiserum also stained granulosa cells of the ovarian follicles,
cells within the islets of Langerhans in the pancreas, and,
very lightly, Sertoli cells and different cell types of the sper-
matogenetic process in the testes. Moderate immunoreac-
tivity was detected in heart and pineal gland, whereas spleen
and lung showed faint staining.
All isoenzymes were detected in the cerebellum (Fig.
7). However, within the cerebellum, the PKC isoenzymes
showed a differential regional, cellular, and subcellular dis-
tribution. In this brain region and in all other organs and tis-
sues examined, immunostaining was always located in the
cytoplasm of the immunostained cells. In the cerebellum,
the staining was also located mainly in the cytoplasm of Pur-
kinje cells or Golgi cells; however, some of the antisera also
stained the processes of Purkinje cells, basket cells, and
Bergmann glial cells in the cerebellum. Finally, it should
be noted that our Western blot and immunocytochemical
findings complement each other in all cases except for liver.
Here, immunohistochemistry failed to detect any of the
isoenzymes in liver, although PKCa,-S, and -~ were detected
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by Western blot. In an effort to remove all exogenous cells
or proteins from liver, this organ was perfused and then
resubjected to Western blot analyses. The patterns of immu-
noblotting were identical to the nonperf ised tissues. Hence,
the nature of the discrepancy between the Western blot and
immunocytochemical analyses is unclear at this time.
Discussion
Elucidation of the regulation and function of PKC in trans-
membrane signalling processes has been rendered more
complex with the identification of multiple members of this
family. The PKC isoenzymes can be grouped into two sub-
families depending on their requirement for calcium (36),
which may impart a limited selectivity in the regulation of
these isoenzymes. A major distinguishing feature that
emerged from previous studies on the tissue distribution of
the calcium-dependent subgroup of the PKC isoenzymes
(PKCa, -ß,, -ßn, and -7) relates to their selective, but over-
lapping, distribution. This information has been obtained
from limited Northern blot analysis of mRNA (6, 25, 38, 40)
and from studies using Western blot analysis (27, 29, 46, 56).
Various cytochemical studies have identified the calcium-
dependent isoenzymes in specific tissues: brain shows
differential distribution of the three isoenzymes (2, 15, 16,
18, 27, 52, 54); pancreas expresses the PKCa and -ßa iso-
forms but not PKCy or -ßt (21, 43); adrenocortical and Ser-
toli cells contain PKCa, whereas Leydig cells express
PKCa, -ß,, and -7(46) ; human leukemia cells contain the
PKCa and -ß subtypes (14, 48) and possibly the PKCy sub-
type (31); and bovine aortic tissues express the type III
(PKCa) isoenzyme (55) .
By contrast, the absence of information on the tissue dis-
tribution of the calcium-independent subgroup of PKC
isoenzymes (PKCS, -e, -e', and -~) limits our understanding
oftheir roles in normal and pathophysiologic circumstances.
Therefore, we examined the tissue distribution of PKC iso-
enzymes by Western blot studies as well as immunohisto-
chemistry. To this end, we have developed nine antisera
specific for each of the known PKC isoenzymes. (While this
study was in progress, an additional PKC isoenzyme was
cloned that shows highest homology to PKCe [3, 45]) . Char-
acterization of these antisera demonstrated their high titer of
reactivity, high specificity, and high binding affinity.
The specificity of these isoenzymes is emphasized by the
following observations. First, the antisera show high affini-
ties and specificities to the respective immunizing peptides.
Second, these antisera detect the appropriate PKC isoen-
zymes from rat brain, which can be distinguished by their
size on SDS-PAGE. In addition, this immunostaining in both
Western blots and immunocytochemistry can be blocked by
coincubation with the immunizing peptide. The isoenzymes
with similar (80-kD) molecular mass can be separated on
hydroxyapatite chromatography. PKCa -ß,, -ßtt, and -y can
be resolved by this procedure, and these isoenzyme-specific
antisera react specifically with each of the respective re-
solved peaks on hydroxyapatite. PKCS, which also has a mo-
lecular mass of 80 kD, does not copurify with the calcium-
dependent isoenzymes when a sequential separation scheme
is applied. Hence, purification of the calcium-dependent
isoforms is not hindered by other possible contaminating
species.An important observation emerged from Western blot
analysis of hydroxyapatite-resolved PKC isoenzymes. These
studies demonstrate that the calcium-independent isoen-
zymes do not copurify with the calcium-dependent ones
when sequential chromatography is used; therefore, the
former are not detected following hydroxyapatite chromatog-
raphy. The calcium-independent isoenzymes are separated
from the calcium-dependent isoforms during DEAE chro-
matography since they elute at higher salt concentrations
(data not shown). This observation should permit the investi-
gation of purified isoenzymes from various tissues.
The eight PKC isoenzymes examined in this study show
distinctive tissue distribution. PKCcx was detected in all tis-
sues examined, including spleen and liver. These findings
are supported by a limited Northern blot study in which
PKCce mRNA was detected in brain, muscle, lung, and kid-
ney (38). Also, Kosaka et al. (27) detected PKCce im-
munoreactivity in all peripheral organs examined. On the
other hand, Yoshida et al. (56) detected PKCca immunoreac-
tivity in brain, pineal gland, retina, and spleen, but not in
pituitary gland, thymus, liver, muscle, heart, lung, or intes-
tine. Our results are more in line with the former studies, be-
cause we confirm the ubiquitous presence of PKC« in all
tissues.
Compared to PKCa, PKC0. and -ßn were more restricted
in their distribution because they were localized primarily in
the brain and spleen. This result is consistent with Northern
blot studies (25) and in situ hybridization (6). By Western
blot, we found PKCy to be restricted to brain, as previously
seen with other Northern and Western blot analyses (25, 27,
56) . By immunohistochemistry, however, we did detect
modest reactivity in adrenal gland. Our results suggest that
PKCy may be selectively expressed in cells derived from the
neural crest.
The tissue distribution of the calcium-independent PKC
isoenzymes (PKCS, -e, and -D has not been previously deter-
mined. In this study, we detected PKC6 in a number of tis-
sues, primarily brain, ovary, lung, and spleen . PKCe shows
reactivity in brain by both Western blot and immunocyto-
chemical analyses. Using this latter approach, we also
identified additional staining in other peripheral tissues.
PKCe' was found predominantly in the brain, with very weak
staining in other peripheral tissues. Interestingly, PKCywas
found by Western blot to be present in many tissues. This
isoenzyme was predominantly localized in endocrine and
blood-forming organs such as the pituitary and adrenal
glands, pancreas, brain, ovaries, testes, lung, liver, and
spleen.
The selective organ distribution of these various PKC
isoenzymes provides a first approximation of theirfunctional
role. On the other hand, the presence ofmultiple isoenzymes
in the same tissue and even within the same cell type suggests
that individual isoenzymes may mediate distinct cellular
functions. This distribution raises important questions as to
how these isoenzymes could be selectively regulated and
how theirphosphorylated substrates could selectively modu-
late these cellular events under various physiologic and
pathologic conditions. These isoenzyme-specific antisera
should permit a detailed examination not only of the subcel-
lular localization and/or translocation of individual isoen-
zymes within the same cell type, but they should also serve
as an additional biochemical tool to examine the potential for
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selective regulation or substrate phosphorylation by these
isoenzymes.
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